Losartan improves intestinal mucositis induced by 5-fluorouracil in mice
Abstract Intestinal mucositis (IM) is a common side effect of 5-fluorouracil (5-FU)-based chemotherapy, which negatively impacts therapeutic outcomes and delays subsequent cycles of chemotherapy resulting in dose reductions and treatment discontinuation. In search of new pharmacological alternatives...
Guardado en:
Autores principales: | Maisie Mitchele Barbosa Oliveira, Aurigena Antunes de Araújo, Susana Barbosa Ribeiro, Polyana Crislayne Moreira de Sales Mota, Vitória Barros Marques, Conceição da Silva Martins Rebouças, Jozi Godoy Figueiredo, Patrícia Batista Barra, Gerly Anne de Castro Brito, Renata Ferreira de Carvalho Leitão, Gerlane Coelho Bernardo Guerra, Caroline Addison Carvalho Xavier de Medeiros |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be1d8a9f27ec4e22b6204f40e7d6e1ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model.
por: Aurigena Antunes de Araújo, et al.
Publicado: (2014) -
In vitro-in vivo availability of metformin hydrochloride-PLGA nanoparticles in diabetic rats in a periodontal disease experimental model
por: Aline de Sousa Barbosa Freitas Pereira, et al.
Publicado: (2021) -
Amelioration of 5-fluorouracil-induced intestinal mucositis by Streptococcus thermophilus ST4 in a mouse model.
por: Siou-Ru Shen, et al.
Publicado: (2021) -
5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging.
por: Chung-Ta Chang, et al.
Publicado: (2012) -
Managing blood pressure control in Asian patients: safety and efficacy of losartan
por: Cheung TT, et al.
Publicado: (2014)